520.85
+2.62%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Lincoln Pharmaceuticals
Its shares trade on NSE under the ticker LINCOLN.NS. It has been listed since 8 February 1996. In the fiscal year to 31 March 2025, it reported revenue of ₹6.23bn and net income of ₹823.5m. At that date it held total assets of ₹7.97bn and shareholders' equity of ₹6.72bn.
Lincoln Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, liquid in bott, liquid injection and pharma products. The company has operations in cardiac, diabetic, anti-malarial, anti-biotics, cephalosporins, analgesic, antipyretics, vitamin-minerals and iron preparations, among others. The firm serves approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia and 26 States across India. The firm's products include ARHL Tablet (used to treat chloroquine resistant falciparum malaria symptoms), Ibuprofen Tablet (used to treat pain, fever, and inflammation), Dolomol Tablet (used to treat aches and pains), Namcold Tablet (used to treat common cold symptoms) and Tinnex Capsule used to treat tinnitus.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 8 Feb 1996
- Employees
- 1,700
- Website
- lincolnpharma.com ↗
Leadership
Pay as last reported
- Mr. Ashish PatelWhole Time Director, since 2014₹6.8m
- Mr. Hasmukhbhai PatelWhole Time Director, since 1995₹3.8m
- Mr. Munjal PatelWhole Time Director, since 2014₹7.0m
- Mr. Kishor ShahNon-Executive Non-Independent Chairman of the Board
- Mr. Darshit ShahChief Financial Officer
- Ms. Trusha ShahCompliance Officer, Company Secretary
- Mr. Mahendrabhai PatelManaging Director, Executive Director₹5.1m
- Mr. Rajnikant PatelNon-Executive Non-Independent Director, since 2018₹1.2m
- Ms. Seema MehtaNon-Executive Woman Independent Director
- Mr. Saurin ParikhNon-Executive Independent Director
- Mr. Nareshkumar SutharNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Lincoln Pharmaceuticals Ltd. employs 1,700 full-time employees in Ahmedabad, Gujarat.
- The company serves 60 countries across Europe, Latin America, Africa, and Asia Pacific.
- Lincoln's product portfolio includes ARHL Tablet for malaria treatment and Ibuprofen for pain relief.
Weaknesses
- Lincoln Pharmaceuticals operates in 26 Indian states but lacks global market dominance.
- The company's product range focuses on specific therapeutic areas like cardiac and diabetic treatments.
- Lincoln's operations are limited to pharmaceutical manufacturing without diversification into other sectors.
Opportunities
- Expanding into new markets in Southeast Asia could increase Lincoln's global presence.
- Lincoln can leverage its existing product lines like Dolomol Tablet for broader applications.
- The growing demand for anti-malarial treatments in Africa presents a significant opportunity.
Threats
- Competition from established pharmaceutical firms in Europe and Asia poses a challenge.
- Regulatory changes in key markets like Africa and Latin America could impact operations.
- Economic downturns in emerging markets may reduce demand for Lincoln's products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.